The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

The supplement tricaprin, which is found in coconut or MCT oil, improved long-term survival for people with triglyceride ...

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Failure occurs when the left ventricle is no longer able to do so adequately, Left-ventricular heart failure is diagnosed when the ejection fraction (meaning the percentage of blood pumped with each ...

February 17, 2025 - DALLAS The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally ...

The study identified five key variables—nonsustained ventricular tachycardia, syncope, male sex, age, and left ventricular ejection fraction —to create a predictive model for estimating the ...

Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...

New research reveals tricaprin, a natural supplement found in coconut oil and dairy, significantly improves survival rates and heart function in TDCV patients.